← Back to patent-cliff list
CAS 113-24-6
Codes: Sodium Pyruvate
Application context (from source-drug indications)
Idiopathic pulmonary fibrosisSodium Pyruvate新冠后遗症Sodium PyruvateCOVID-19Sodium PyruvateChronic obstructive pulmonary diseaseSodium PyruvateProstate cancerSodium PyruvateAsthmaSodium Pyruvate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Sodium Pyruvate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
sodium 2,2-dihydroxypropanoate→Sodium Pyruvate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.